Similar Papers

Paper Title
Journal
Date
Author
Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups
Ruth Pettengell ... Matthias Schwenkglenks
Leukemia & Lymphoma | VOL. 52
Ruth Pettengell, et. al.Ruth Pettengell ... Matthias Schwenkglenks
11 Feb 2011
Evaluation of efficacy and safety of pegfilgrastim when given less than two weeks from dose-dense chemotherapy regimens.
Godsfavour O Umoru ... Hanna Zaghloul
Journal of Oncology Pharmacy Practice | VOL. 27
Godsfavour O Umoru, et. al.Godsfavour O Umoru ... Hanna Zaghloul
12 Aug 2020
Randomized double-blind controlled trial (RCT) of pegfilgrastim as prophylactic therapy in pediatric patients with solid tumors during myelosuppressive chemotherapy.
S E Anaya Aguirre ... F Cerecedo Diaz
Journal of Clinical Oncology | VOL. 29
S E Anaya Aguirre, et. al.S E Anaya Aguirre ... F Cerecedo Diaz
20 May 2011
Pharmacoeconomics of the Myeloid Growth Factors
Bradford R Hirsch ... Gary H Lyman
PharmacoEconomics | VOL. 30
Bradford R Hirsch, et. al.Bradford R Hirsch ... Gary H Lyman
01 Jun 2012
View more papers

More From: Pediatric Hematology Oncology Journal

Paper Title
Journal
Date
Author
Corrigendum to < Peg-asparaginase associated toxicities in children with acute lymphoblastic leukemia: A single-center cross-sectional study > Pediatric Hematology Oncology Journal, Volume 9, Issue 1,2024, Pages 54-62, ISSN 2468-1245, https://doi.org/10.1016/j.phoj.2024.03.001
Sameh Awwad ... Issam Alfayyad
Pediatric Hematology Oncology Journal | VOL. -
Sameh Awwad, et. al.Sameh Awwad ... Issam Alfayyad
01 Dec 2024
Curative Hematopoietic Stem Cell Transplantation in a child with Specific Granule Deficiency due to a homozygous SMARCD2 variant
Janaki Menon ... Geeta Madathil Govindaraj
Pediatric Hematology Oncology Journal | VOL. 9
Janaki Menon, et. al.Janaki Menon ... Geeta Madathil Govindaraj
01 Dec 2024
Editorial Board Information
-
Pediatric Hematology Oncology Journal | VOL. 9
--
01 Dec 2024
A rare mutation, deletion of HBB intron 2 to HBG1 exon 3 gene regions (12.6 kb) along with c.27dup, leading to transfusion-dependent thalassemia
Dolat Singh Shekhawat ... Kuldeep Singh
Pediatric Hematology Oncology Journal | VOL. -
Dolat Singh Shekhawat, et. al.Dolat Singh Shekhawat ... Kuldeep Singh
01 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.